Epigenetics and aging S Pal, JK Tyler Science advances 2 (7), e1600584, 2016 | 892 | 2016 |
Mechanisms and therapeutic implications of hypermutation in gliomas M Touat, YY Li, AN Boynton, LF Spurr, JB Iorgulescu, CL Bohrson, ... Nature 580 (7804), 517-523, 2020 | 562 | 2020 |
Nucleosome loss leads to global transcriptional up-regulation and genomic instability during yeast aging Z Hu, K Chen, Z Xia, M Chavez, S Pal, JH Seol, CC Chen, W Li, JK Tyler Genes & development 28 (4), 396-408, 2014 | 347 | 2014 |
Cas9 activates the p53 pathway and selects for p53-inactivating mutations OM Enache, V Rendo, M Abdusamad, D Lam, D Davison, S Pal, ... Nature genetics 52 (7), 662-668, 2020 | 271 | 2020 |
Influenza A virus interacts extensively with the cellular SUMOylation system during infection S Pal, A Santos, JM Rosas, J Ortiz-Guzman, G Rosas-Acosta Virus research 158 (1-2), 12-27, 2011 | 97 | 2011 |
SUMOylation affects the interferon blocking activity of the influenza A nonstructural protein NS1 without affecting its stability or cellular localization A Santos, S Pal, J Chacón, K Meraz, J Gonzalez, K Prieto, ... Journal of virology 87 (10), 5602-5620, 2013 | 65 | 2013 |
Cross-talk between lysine-modifying enzymes controls site-specific DNA amplifications S Mishra, C Van Rechem, S Pal, TL Clarke, D Chakraborty, SD Mahan, ... Cell 174 (4), 803-817. e16, 2018 | 60 | 2018 |
Impaired cohesion and homologous recombination during replicative aging in budding yeast S Pal, SD Postnikoff, M Chavez, JK Tyler Science advances 4 (2), eaaq0236, 2018 | 55 | 2018 |
Identification of the non-structural influenza A viral protein NS1A as a bona fide target of the Small Ubiquitin-like MOdifier by the use of dicistronic expression constructs S Pal, JM Rosas, G Rosas-Acosta Journal of virological methods 163 (2), 498-504, 2010 | 46 | 2010 |
Epigenetics and aging. Sci. Adv. 2016; 2 (7): e1600584 S Pal, JK Tyler | 32 | |
VRK1 as a synthetic lethal target in VRK2 promoter–methylated cancers of the nervous system J So, NW Mabe, B Englinger, KH Chow, SM Moyer, S Yerrum, MC Trissal, ... JCI insight 7 (19), e158755, 2022 | 20 | 2022 |
Proteomic identification of histone post-translational modifications and proteins enriched at a DNA double-strand break P Wang, S Byrum, FC Fowler, S Pal, AJ Tackett, JK Tyler Nucleic acids research 45 (19), 10923-10940, 2017 | 20 | 2017 |
Delineation of the role of chromatin assembly and the Rtt101Mms1 E3 ubiquitin ligase in DNA damage checkpoint recovery in budding yeast LT Diao, CC Chen, B Dennehey, S Pal, P Wang, ZJ Shen, A Deem, ... PloS one 12 (7), e0180556, 2017 | 20 | 2017 |
The Commercial Antibodies Widely Used to Measure H3 K56 Acetylation Are Non-Specific in Human and Drosophila Cells S Pal, H Graves, R Ohsawa, T Huang, P Wang, L Harmacek, J Tyler PLoS One 11 (5), e0155409, 2016 | 19 | 2016 |
Author correction: Cas9 activates the p53 pathway and selects for p53-inactivating mutations OM Enache, V Rendo, M Abdusamad, D Lam, D Davison, S Pal, ... Nature Genetics 52 (7), 748-749, 2020 | 16 | 2020 |
Surgical window of opportunity trial reveals mechanisms of response and resistance to navtemadlin (KRT-232) in patients with recurrent glioblastoma V Rendo, EQ Lee, C Bossi, N Khuu, MA Rudek, S Pal, ARN Reynolds, ... medRxiv, 2024.08. 12.24311893, 2024 | | 2024 |
20/# 1057 Integrated profiling of a prospective endometrial cancer organoid biobank reveals high heterogeneity H Berg, M Hjelmeland, H Lien, H Espedal, S Pal, A Srivastava, T Stokowy, ... International Journal of Gynecological Cancer 32, A34-A35, 2022 | | 2022 |
EXTH-95. UNCOVERING THERAPEUTIC VULNERABILITIES IN MISMATCH REPAIR-DEFICIENT GLIOMAS S Pal, A Boynton, R Johnston, N Currimjee, K Qian, M Touat, C Bellamy, ... Neuro-Oncology 24 (Supplement_7), vii231-vii232, 2022 | | 2022 |
HGG-32. UNCOVERING THERAPEUTIC VULNERABILITIES IN MISMATCH REPAIR-DEFICIENT GLIOMAS A Boynton, S Pal, M Touat, N Currimjee, K Qian, C Bellamy, P Ho, ... Neuro-Oncology 22 (Suppl 3), iii349, 2020 | | 2020 |
DRES-08. CLINICAL SIGNIFICANCE OF HYPERMUTATION IN GLIOMAS M Touat, Y Li, A Boynton, L Spurr, B Iorgulescu, C Birzu, S Pal, ... Neuro-oncology 21 (Supplement_6), vi73-vi73, 2019 | | 2019 |